Skip to main content
Industry Resources
Displaying 217 - 228 of 488
Display:
12
24
48
Viral Hepatitis
Benefits and barriers to achieving functional cure
Webcasts
View
Viral Hepatitis
The importance of quantitative hepatitis B surface antigen in achieving functional cure: A clinical perspective
Webcasts
View
Immune-Mediated and Cholestatic Diseases
What is the unmet burden of itch from a patient perspective?
Webcasts
View
Immune-Mediated and Cholestatic Diseases
IBAT inhibition: a tool for the future?
Webcasts
View
Immune-Mediated and Cholestatic Diseases
What are the unmet needs in PBC according to a patient advocate?
Webcasts
View
Viral Hepatitis
Strategies for achieving functional cure
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Why is holistic care important for patients with PBC?
Webcasts
View
Immune-Mediated and Cholestatic Diseases
What can we learn about holistic care to manage cholestatic pruritus in PBC from a UK healthcare setting?
Webcasts
View
Immune-Mediated and Cholestatic Diseases
What can we learn about holistic care to manage cholestatic pruritus in PBC from a US healthcare setting?
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Closing remarks
Webcasts
View
Viral Hepatitis
Are we Overcomplicating HCV Elimination?
Webcasts
View
Viral Hepatitis
Bringing Everyone into the Equation
Webcasts
View
Pagination
First page
« First
Previous page
‹ previous
…
Page
15
Page
16
Page
17
Page
18
Current page
19
Page
20
Page
21
Page
22
Page
23
…
Next page
next ›
Last page
Last »
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Content Access policy
Privacy Policy
Cookie Policy